VVAX Holdings Limited Plans to Sell Ordinary Shares of Zhengye Biotechnology Holding Limited

VVAX Holdings Limited has filed a Form 144 with the SEC, indicating its intention to sell 684,996 ordinary shares of Zhengye Biotechnology Holding Limited. The shares were acquired on June 21, 2023, through a cash purchase. The approximate sale date is set for November 1, 2025, with an aggregate market value of $1,794,690.00. The shares are listed on NASDAQ, and the transaction will be facilitated by AC Sunshine Securities LLC. VVAX Holdings Limited has reported no securities sold in the past three months. The filing was signed by Zhenfa Han on October 22, 2025.